Vlado Perkovic's Publications
About Vlado Perkovic's Publications
Board Member- MBBS,
- PhD,
- FASN,
- FRACP
-
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials
American Journal of Kidney Diseases Date published: -
MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS
Nephrology Dialysis Transplantation Date published: -
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Cochrane Database of Systematic Reviews Date published: -
ALTITUDE: defining a ceiling for blockade of the renin-angiotensin system?
The Lancet Diabetes & Endocrinology Date published: -
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Diabetes Care Date published: -
The Affordable Dialysis Prize steams ahead
The Lancet Date published: -
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
The Lancet Date published: -
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial
Redox Report Date published: -
Canagliflozin (CANA) Slows Progression of Renal Function Decline Independent of Glycemic Effects
Date published: -
EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS
Date published: -
IS IMMUNOSUPPRESSIVE THERAPY BENEFICIAL FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SYSTEMATIC REVIEW AND TRIAL SEQUENTIAL ANALYSIS OF PUBLISHED TRIALS
Date published: -
Canagliflozin slows progression of renal function decline independent of glycaemic effects
Date published: -
TRENDS IN THE RELATIVE SURVIVAL OF MIDDLE AGED AND OLDER PEOPLE ON DIALYSIS IN AUSTRALIA
Date published: -
TRENDS IN HAEMOGLOBIN CONCENTRATION AND ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IN THE AUSTRALIAN DIALYSIS POPULATION
Date published: -
Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes
Diabetes, Obesity and Metabolism Date published: -
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Sao Paulo Medical Journal Date published:
